Rethinking Clinical Trials

FEBRUARY 14, 2024

DCP planned to launch 5 sites in the first year starting with the Boston Healthcare System. Other key success factors were the creative thinking across the study team and the excellent study coordination and partnership within the health system. DCP aimed to recruit 13,500 patients across the U.S. from 72 VA healthcare systems.

Clinical Trials 154

Clinical Trials Clinical Trials Cardiology Trials 154

XTalks

JUNE 8, 2021

With a price tag of over $2.5 In March, the National Institute for Health and Care Excellence (NICE) and the Scottish Medicines Consortium in Scotland both recommended that the gene therapy be used by the NHS for babies up to the age of 12 months with type I SMA. million, Zolgensma is currently the world’s most expensive drug.

Gene Therapy 110

Gene Therapy Gene Protein Trials 110

pharmaphorum

MAY 24, 2021

Robb DeFilippis, managing director, life sciences, for end-to-end global creative production and sourcing partner Tag in the Americas agrees. As the leading creative production partner to brands and agencies, Tag offers a complementary skillset to in-house teams and advertising agencies to bring to life, extend and deploy creative ideas.

Marketing 102

Marketing Branding Sales Life Science 102

Cloudbyz

JUNE 1, 2023

Auto-launched Flows: These are flows that run in the background, requiring no user interaction. Export and Print: You can export reports and dashboards to Excel or other formats for further analysis, or you can print them. Users can also collaborate on files, add comments, and tag colleagues.

Compliance 78

Compliance Development Branding Production 78

Pharmaceutical Technology

NOVEMBER 30, 2022

In the first quarter since its launch as an approved therapy for type 2 diabetes, Mounjaro has proven to be a lucrative drug, making $97.3 The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. million in Q3. compared to a 5.1%

Drugs 264

Drugs Manufacturing Hormones Contract Manufacturing 264

Pharmaceutical Technology

NOVEMBER 30, 2022

In the first quarter since its launch as an approved therapy for type 2 diabetes, Mounjaro has proven to be a lucrative drug, making $97.3 The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. million in Q3. compared to a 5.1%

Drugs 246

Drugs Manufacturing Hormones Contract Manufacturing 246